BIMI International Medical Inc chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 1.32
Dividend & YieldN/A$ (N/A)
Beta 0.07
Market capitalization 8.14M
Operating cash flow -6.06M
ESG Scores unknown

Company description

BIMI International Medical Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People's Republic of China. The company operates in four segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. It distributes Stryker spinal products, Olympus endoscopes, imported imaging products, and diagnostic imaging equipment to drug stores, private clinics, pharmaceutical dealers, and hospitals in the Southwest region of the People's Republic of China. The company also distributes generic drugs, Chinese herbal medicine, biochemical drugs, raw ingredients for pharmaceutical products, antibiotics, cardiovascular drugs, and anti-obesity medicines. In addition, it offers prescription and over-the-counter drugs, nutritional supplements, health foods, sundry products, traditional Chinese medicines, personal and family care products, medical devices, and miscellaneous items under the Lijiantang Pharmacy brand name. Further, the company provides medical services in the hospitals, as well as IT research and development services. It sells its medicine and other healthcare products to customers through its directly owned stores. The company was formerly known as BOQI International Medical Inc. and changed its name to BIMI International Medical Inc. in June 2021. BIMI International Medical Inc. was incorporated in 2000 and is based in Chongqing, the People's Republic of China.

Sector: Healthcare - Industry: Pharmaceutical Retailers

Financial Ratios
Quick Ratio0.7
Working Capital37.52
Return On Equity-3.13
Debt To Equity0.05
Fixed Asset Ratio0
Fixed Interest Cover-23.09

Financial data

Diluted earning per share

Net income vs Operating income

Asset vs Liabilities

Financial Statements

Cashflow Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities 4.55M -453.74k
Total Cashflows From Investing Activities 166.72k 166.72k -724.47k -696.52k
Net Borrowings 837.81k 837.81k 3.84M 6.62M
Total Cash From Financing Activities 211.26k 1.84M 3.99M 6.14M
Change To Operating Activities 18k -75.57k -1.59M 8.84M
Issuance Of Stock 500k
Net Income -16.79M -4.44M -2M -34.99M
Change In Cash 1.6k 1.6k 133.71k 4.66M
Effect Of Exchange Rate 132.71k 63.57k 386.84k 494.24k
Total Cash From Operating Activities -343.97k -2.06M -3.52M -1.28M
Depreciation 56.04k 56.04k 56.04k 240.66k
Change To Account Receivables -5M -5M -5M 685.43k
Other Cashflows From Financing Activities -288.74k 998.29k 148.7k -478.18k
Change To Netincome 16.42M 2.34M -789.3k 26.23M
Capital Expenditures -258.96k -258.96k -258.96k -814.68k

Income Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Research Development
Income Before Tax -212.58k -1.54M -3.35M -34.9M
Net Income -16.79M -4.44M -2M -34.99M
Selling General Administrative 212.58k 985.97k 6.26M 12.7M
Gross Profit 2.44M 4.6M
Ebit -212.58k -985.97k -3.81M -8.11M
Operating Income -212.58k -985.97k -3.81M -8.11M
Interest Expense -6.35k -6.35k -84.91k -351.07k
Income Tax Expense 434.31k 19.37k
Total Revenue 12.84M 27.08M
Cost Of Revenue 10.4M 22.48M
Total Other Income ExpenseNet -550.06k 460.55k -26.8M
Net Income From Continuing Ops -212.58k -1.54M -3.79M -34.92M
Net Income Applicable To Common Shares -16.79M -4.44M -2M -34.99M

Balance Sheet Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 13.07M 21.55M 16.31M 26.79M
Total Stockholder Equity 10.14M 8.68M 16.71M 11.19M
Other Current Liabilities 12.81M 21.26M 4.36M 4.09M
Total Assets 23.05M 30.06M 33.2M 38.13M
Common Stock 7.57k 9.07k 2.65k 8.5k
Other Current Assets 23.05M 30.05M 13.22M 1.91M
Retained Earnings -4.22M -8.65M -10.65M -45.64M
Treasury Stock 1.79M 1.68M 1M 1.6M
Cash 1.6k 135.31k 4.8M
Total Current Liabilities 13.07M 21.55M 15.57M 22.09M
Other Stockholder Equity 1.79M 1.68M 1M 1.6M
Property, Plant, and Equipment 910.21k 8.37M
Total Current Assets 23.05M 30.06M 25.18M 21.16M
Net Tangible Assets 10.14M 8.68M 9.8M 2.8M
Net Receivables 3.92k 8.34M 8.35M
Accounts Payable 5.85M 7.34M


Insider Transactions

Here are the insider transactions of stock shares related to BIMI International Medical Inc:

Filer Name Transaction Text Ownership Date Filer Relation Shares
SONG TIEWEIStock Award(Grant) at price 0.50 per share.D2022-07-19Chief Executive Officer100k
OUDOM FNUStock Award(Grant) at price 0.40 per share.D2022-07-19Chairman of the Board12.5M
SONG TIEWEIStock Award(Grant) at price 0.46 per share.D2022-07-18Chief Executive Officer124.43k
LIHUA WANGSale at price 1.44 per share.I2018-04-09Chief Financial Officer200k
GANG LISale at price 1.40 per share.I2018-04-09Chief Executive Officer800k
LIHUA WANGSale at price 0.20 per share.I2009-06-17Chief Financial Officer188.11k
GANG LISale at price 0.00 per share.I2009-06-17Chief Executive Officer752.43k
LIAONING NENGFA WEIYE NEW ENERGY APPLICATION CO LTDSale at price 0.20 per share.I2009-06-17Beneficial Owner of more than 10% of a Class of Security940.54k
LIHUA WANGSale at price 0.20 per share.I2009-05-28Chief Financial Officer1.16M
GANG LISale at price 0.20 per share.I2009-05-28Chief Executive Officer4.66M
LIAONING NENGFA WEIYE NEW ENERGY APPLICATION CO LTDSale at price 0.20 per share.I2009-05-28Beneficial Owner of more than 10% of a Class of Security5.82M
LIHUA WANGPurchase at price 0.05 per share.I2008-01-10Chief Financial Officer5.16M
LIHUA WANGSale at price 0.02 per share.D2008-01-10Chief Financial Officer5.82M
GANG LIPurchase at price 0.05 per share.I2008-01-10Chief Executive Officer20.65M
GANG LISale at price 0.06 per share.D2008-01-10Chief Executive Officer19.99M

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to BIMI International Medical Inc. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on BIMI International Medical Inc

Here is the result of two systematic investment strategies applied to BIMI International Medical Inc. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on BIMI International Medical Inc

The following chart shows the equity curve of the two systematic investment strategies applied to BIMI International Medical Inc:

BIMI International Medical Inc automated entries

The systematic investment strategy that buys the first day of the month would give a performance of -74.54% on the backtest period.

Performance at glance

Performance

-74.54 %

Latent gain

-1305.68 $

Invested capital

1751.56 $

Annualized return

-18.18 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on BIMI International Medical Inc

This is the result of two momentum investment strategies applied to BIMI International Medical Inc. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on BIMI International Medical Inc

The following chart shows all the entries opened by the momentum investment system on BIMI International Medical Inc:

BIMI International Medical Inc momentum entries
  • The first momentum investment strategy would give -56.9% of return on BIMI International Medical Inc. That represents -3270.87$ of latent gain with 5748.77$ of employed capital.
  • The second momentum investment strategy would give -60.47% of return on BIMI International Medical Inc. That represents -2721.86$ of latent gain with 4501.12$ of employed capital.
Performance at glance (1Q Momentum)

Performance

-56.9 %

Latent gain

-3270.87 $

Invested capital

5748.77 $

Annualized return

0.0 %
Performance at glance (2Q Momentum)

Performance

-60.47 %

Latent gain

-2721.86 $

Invested capital

4501.12 $

Annualized return

-16.7 %

Momentum equity curve on BIMI International Medical Inc

The following chart shows the equity curve of the two momentum strategies applied to BIMI International Medical Inc:

BIMI International Medical Inc momentum equity

Note: the dividends potentially given by BIMI International Medical Inc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on BIMI International Medical Inc

The following chart shows the employed capital evolution of the two momentum strategies on BIMI International Medical Inc since the beginning:

BIMI International Medical Inc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on BIMI International Medical Inc

Buy the dip entry openings on BIMI International Medical Inc

BIMI International Medical Inc

The performance achieved by the robo-advisor on BIMI International Medical Inc is 0%. That represents 0.0$ of latent gain with 0.0$ of employed capital. The following chart shows BIMI International Medical Inc stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of BIMI International Medical Inc, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

0 %

Latent gain

0.0 $

Invested capital

0.0 $

Annualized return

0.0 %

Equity curve of the strategy applied to BIMI International Medical Inc

The following chart shows the result of the investment strategy applied to BIMI International Medical Inc:

BIMI International Medical Inc

Note: the dividends potentially given by BIMI International Medical Inc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on BIMI International Medical Inc

The following chart shows the employed capital evolution since the beginning of the investment strategy on BIMI International Medical Inc:

BIMI International Medical Inc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on BIMI International Medical Inc

In this section, I will compare the three previous investment strategies applied to BIMI International Medical Inc.

Equity curve comparison on BIMI International Medical Inc

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

BIMI International Medical Inc investment strategy comparison

Employed capital comparison on BIMI International Medical Inc

BIMI International Medical Inc investment comparison

Performance comparison on BIMI International Medical Inc

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment -74.54% -1305.68$ 1751.56$ -18.18%
Momentum 1 quarter -56.9% -3270.87$ 5748.77$ -14.74%
Momentum 2 quarters -60.47% -2721.86$ 4501.12$ -16.7%
Non-directional 0% 0.0$ 0.0$ 0.0%
Annualized return comparison

Automatic investment

-18.18 %

Momentum 1Q

-16.7 %

Momentum 2Q

-16.7 %

Non-directional

0.0 %

Correlated stocks

Here are the most positively and negatively correlated stocks with BIMI International Medical Inc:

Positive correlations

Most correlated stocks this year

  • BIMI International Medical Inc

  • Most correlated stocks last 3 months

  • BIMI International Medical Inc

  • Negative correlation

    Most negatively correlated stocks this year


    Most negatively correlated stocks last 3 months

  • HK CHAOSHANG GP

  • Note: The algorithm computes the probability of correlation between BIMI International Medical Inc and the other stocks. There may be false positives or some missing correlated stocks. If the price of BIMI International Medical Inc does not vary for 36 weeks, the correlation calculation result will be wrong.


    Company information

    Company name BIMI International Medical Inc
    Country China
    City Chongqing
    Address Chongqing Corporation Avenue
    Phone 86 23 6310 7239
    Website www.usbimi.com/index.html
    FullTime employees 524
    Industry Pharmaceutical Retailers
    Sector Healthcare
    Exchange XNAS
    Ticker BIMI
    Market www.nasdaq.com

    BIMI International Medical Inc ESG Scores

    Environment scores

    Environment ESG Factors Scores
    Environment Score 0
    Peer Environment Performance unknown
    Environment Percentile unknown
    Palm Oil unknown
    Nuclear unknown
    Fur Leather unknown
    GMO unknown
    Coal unknown
    Pesticides unknown
    Animal Testing unknown

    Social scores

    Social ESG Factors Scores
    Social Score 0
    Peer Social Performance unknown
    Social Percentile unknown
    Highest Controversy unknown
    Peer Highest Controversy Performance unknown
    Adult unknown
    Gambling unknown
    Alcoholic unknown
    Tobacco unknown
    Catholic unknown
    Controversial Weapons unknown
    Small Arms unknown
    Military Contract unknown
    Peer Count unknown

    Related Controversy:


    Governance scores

    Governance ESG Factors Scores
    Governance Score 0
    Peer Governance Performance unknown
    Governance Percentile unknown

    ESG at glance
    Total ESG Scores: unknown
    Environment Score: 0
    Social Score: 0
    Governance Score: 0

    ESG Performance: unknown

    Peer Group: unknown

    Peer Esg Score Performance: unknown

    Rating Year: unknown

    Rating Month: unknown

    Max Age: unknown

    Percentile: unknown